The dosage schedules listed can be used as a general guide for the administration of Lymphomyosot ® Injection Solution. Lymphomyosot ® Injection Solution shows individual differences in clinical response. Therefore, the dosage for each patient should be individualized according to the patient's response therapy. Adults and children 7 years and older: in acute disorders, 1 ampule per day, otherwise 1 ampule, 1 to 3...
Avoid freezing and excessive heat. Store at room temperature. Protect from light.
Injection Solution Ingredient Information: Each 1.1ml ampule contains: Geranium robertianum 4X 1.1 mcl, Nasturtium aquaticum 4X 1.1 mcl, Ferrum iodatum 12X 1.1 mcl, Juglans regia 3X 0.55 mcl, Myosotis arvensis 3X 0.55 mcl, Scrophularia nodosa 3X 0.55 mcl, Teucrium scorodonia 3X 0.55 mcl, Veronica officinalis 3X 0.55 mcl, Equistetum hyemale 4X 0.55 mcl, Fumaria officinalis 4X 0.55 mcl, Natrum sulphuricum 4X 0.55 mcl, Pinus sylvestris 4X 0.55 mcl, Gentiana lutea 5X 0.55 mcl, Aranea diadema 6X 0.55 mcl, Sarsaparilla 6X 0.55 mcl, Calcarea phosphorica 12X 0.55 mcl, Levothyroxine 12X 0.55 mcl. Inactive Ingredients: Sterile Isotonic sodium chloride solution.
Lymphomyosot® Injection Solution is classified as a homeopathic combination drug.
Botanical Ingredients:
Equisetum hyemale (Horsetail), Fumaria officinalis (Common fumitory), Gentiana lutea (Yellow gentian), Geranium robertianum (Herb Robert), Juglans regia (Walnut), Myosotis arvensis (Forget-me-not), Nasturtium aquaticum (Watercress), Pinus sylvestris (Scotch Pine), Sarsaparilla (Wild liquorice), Scrophularia nodosa (Figwort), Teucrium scorodonia (Wood-germander), Veronica officinalis (Common speedwell).
Mineral Ingredients:
Calcarea phosphorica (Tribasic calcium phosphate), Ferrum iodatum (Ferrous iodide), Natrum sulphuricum (Disodium sulfate).
Animal-derived ingredients:
Aranea diadema (Papal-cross spider), Levothyroxine (L-thyroxine).
The dosage schedules listed can be used as a general guide for the administration of Lymphomyosot® Injection Solution. Lymphomyosot® Injection Solution shows individual differences in clinical response. Therefore, the dosage for each patient should be individualized according to the patient's response therapy.
Adults and children 7 years and older: in acute disorders, 1 ampule per day, otherwise 1 ampule, 1 to 3 times per week IM/SC/IV/ID. Children ages 2 to 6: receive 1/2 the adult dosage. Discard unused solution.
Lymphomyosot® Injection Solution may be administered intravenously, intramuscularly, subcutaneously, or intradermally. The required dose of Lymphomyosot® Injection Solution is first withdrawn from the ampule into the syringe, and the syringe is then shaken briefly. Lymphomyosot® Injection Solution should be administered using a narrow gauge needle (e.g. 22 to 30 gauge). Note: Parental drug products like Lymphomyosot® Injection Solution should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. Lymphomyosot® Injection Solution is a clear, colorless solution. Discolored solutions should be discarded.If new syptoms occur, or if redness, pain or swelling at the puncture site persists, the patient should be carefully re-evaluated because these could be signs of a more serious condition.
Lymphomyosot® Injection Solution exhibits no known adverse renal, hepatic, cardiovascular, gastrointestinal or central nervous system side effects.The exact mechanism of action of Lymphomyosot® Injection Solution is not fully understood.
Injections: 1.1 ml ampule
Avoid freezing and excessive heat. Store at room temperature. Protect from light.
Lymphomyosot_injectable box.jpg
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 52919-123-10 | 2025-11-17 | C162847 | 48780-1 | 956f9ecf-ce2b-621f-e053-dbdaa90a74ad | Lymphomyosot 1.1ml Injection |
| 52919-123-10 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-ce2b-621f-e053-dbdaa90a74ad | Lymphomyosot 1.1ml Injection |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 52919-123 | LYMPHOMYOSOT (GERANIUM ROBERTIANUM AND RORIPPA NASTURTIUM-AQUATICUM AND TRIBASIC CALCIUM PHOSPHATE AND LEVOTHYROXINE AND ) INJECTION [HAMELN PHARMA GMBH] | 1 | Legacy NDC | 20100608_8b9820bb-d592-46bf-b1db-f91947bf49aa.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ARANEUS DIADEMATUS | ACTIVE INGREDIENT | 6T6CO7R3Z5 | 1 | |
| EQUISETUM HYEMALE | ACTIVE INGREDIENT | 59677RXH25 | 1 | |
| FERROUS IODIDE | ACTIVE INGREDIENT | F5452U54PN | 1 | |
| FUMARIA OFFICINALIS FLOWERING TOP | ACTIVE INGREDIENT | VH659J61ZL | 1 | |
| GENTIANA LUTEA ROOT | ACTIVE INGREDIENT | S72O3284MS | 1 | |
| GERANIUM ROBERTIANUM | ACTIVE INGREDIENT | R5I1HK0UBL | 1 | |
| JUGLANS REGIA FLOWERING TOP | ACTIVE INGREDIENT | 3BA2N709NG | 1 | |
| LEVOTHYROXINE | ACTIVE INGREDIENT | Q51BO43MG4 | 1 | |
| MYOSOTIS ARVENSIS | ACTIVE INGREDIENT | C73BK97H5J | 1 | |
| PINUS SYLVESTRIS TOP | ACTIVE INGREDIENT | Q1RGP4UB73 | 1 | |
| RORIPPA NASTURTIUM-AQUATICUM | ACTIVE INGREDIENT | YH89GMV676 | 1 | |
| SARSAPARILLA | ACTIVE INGREDIENT | 2H1576D5WG | 1 | |
| SCROPHULARIA NODOSA | ACTIVE INGREDIENT | 7H443NUB2T | 1 | |
| SODIUM SULFATE | ACTIVE INGREDIENT | 0YPR65R21J | 1 | |
| TEUCRIUM SCORODONIA FLOWERING TOP | ACTIVE INGREDIENT | LOK3I16O7G | 1 | |
| TRIBASIC CALCIUM PHOSPHATE | ACTIVE INGREDIENT | 91D9GV0Z28 | 1 | |
| VERONICA OFFICINALIS FLOWERING TOP | ACTIVE INGREDIENT | 9IH82J936J | 1 | |
| ARANEUS DIADEMATUS | ACTIVE MOIETY | 6T6CO7R3Z5 | 1 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 1 | |
| EQUISETUM HYEMALE | ACTIVE MOIETY | 59677RXH25 | 1 | |
| FERROUS IODIDE | ACTIVE MOIETY | F5452U54PN | 1 | |
| FUMARIA OFFICINALIS FLOWERING TOP | ACTIVE MOIETY | VH659J61ZL | 1 | |
| GENTIANA LUTEA ROOT | ACTIVE MOIETY | S72O3284MS | 1 | |
| GERANIUM ROBERTIANUM | ACTIVE MOIETY | R5I1HK0UBL | 1 | |
| JUGLANS REGIA FLOWERING TOP | ACTIVE MOIETY | 3BA2N709NG | 1 | |
| LEVOTHYROXINE | ACTIVE MOIETY | Q51BO43MG4 | 1 | |
| MYOSOTIS ARVENSIS | ACTIVE MOIETY | C73BK97H5J | 1 | |
| PINUS SYLVESTRIS TOP | ACTIVE MOIETY | Q1RGP4UB73 | 1 | |
| RORIPPA NASTURTIUM-AQUATICUM | ACTIVE MOIETY | YH89GMV676 | 1 | |
| SARSAPARILLA | ACTIVE MOIETY | 2H1576D5WG | 1 | |
| SCROPHULARIA NODOSA | ACTIVE MOIETY | 7H443NUB2T | 1 | |
| SODIUM CATION | ACTIVE MOIETY | LYR4M0NH37 | 1 | |
| TEUCRIUM SCORODONIA FLOWERING TOP | ACTIVE MOIETY | LOK3I16O7G | 1 | |
| VERONICA OFFICINALIS FLOWERING TOP | ACTIVE MOIETY | 9IH82J936J | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 52919-123 | 52919-123-10 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 41e7ce28-9538-3cfc-e063-6294a90a277a | 8b9820bb-d592-46bf-b1db-f91947bf49aa | 2025-10-24 | Warnings | 8b9820bb-d592-46bf-b1db-f91947bf49aa |
Adverse event summaries are temporarily unavailable. Other product information remains available.